IPGP » Topics » Employment Agreements

This excerpt taken from the IPGP DEF 14A filed Apr 20, 2009.
Employment Agreements
 
On May 9, 2008, we entered into new employment agreements with each of executives named in the table above. The employment agreements expire on December 31, 2010 for Dr. Gapontsev, and on December 31, 2009 for the other executive officers, and in the event of a change in control, the agreements would be extended to expire on the second anniversary of such change in control.
 
The employment agreements set the annual base salaries for the Named Executive Officers at $380,000 for Dr. Gapontsev, €246,960 for Dr. Shcherbakov, $283,500 for each of Messrs. Mammen and Lopresti and $252,000 for Dr. Ovtchinnikov, effective April 1, 2008. The agreements entitle these executive officers to participate in bonus plans, standard insurance plans such as life, short-term disability and long-term disability insurance and retirement benefits, such as the 401(k) plan and equity award plans described above, on similar


21


Table of Contents

terms and on a similar basis as such benefits are available to executives at similar levels within the organization. Each of these executive officers also entered into a new non-competition agreement with the Company that prohibits each of them from competing with the Company for a period of one year after the termination of his employment with the Company for any reason and from hiring or attempting to hire the Company’s employees or soliciting customers or suppliers of the Company for a period ending eighteen months following the termination of his employment for any reason. Each of the officers is entitled to receive his base salary for the period during which the Company enforces the non-competition provisions of the agreement but not for more than one year following the termination of his employment. The severance provisions of the agreements are described below under “Potential Payments Upon Termination or Change in Control.”
 
This excerpt taken from the IPGP DEF 14A filed Apr 15, 2008.
Employment Agreements
 
On March 1, 2006, we entered into employment agreements with Drs. Valentin P. Gapontsev, Shcherbakov and BuAbbud, and Messrs. Mammen and Lopresti. Each of these agreements has a two-year term, except for Dr. Gapontsev, whose agreement has a three-year term. The employment agreements automatically renew upon the completion of their initial terms for successive one-year period unless either we or the executive officer gives 180 days’ prior written notice of intent not to extend the agreement. The employment agreements set the annual base salaries for the Named Executive Officers at $360,000, €235,200, $270,000, $270,000 and $240,000, respectively. The agreements entitle these executive officers to participate


24


Table of Contents

in bonus plans, standard insurance plans such as life, accidental death and dismemberment, short-term disability and long-term disability insurance and retirement benefits, such as the 401(k) plan and stock option plans described above, on similar terms and on a similar basis as such benefits are available to executives at similar levels within the organization. The agreements for Drs. Gapontsev, Shcherbakov and BuAbbud require each of them to refrain from competing with us for a period of one year following the termination of their employment with us for any reason and from hiring our employees or soliciting our customers for a period ending eighteen months following the termination of their employment with us for any reason. The severance provisions of the agreements are described below under “Potential Payments Upon Termination or Change in Control”.
 
This excerpt taken from the IPGP DEF 14A filed Apr 30, 2007.
Employment Agreements
 
On March 1, 2006, we entered into employment agreements with Dr. Gapontsev, Dr. Shcherbakov, Messrs. Mammen and Lopresti, and Dr. Ovtchinnikov. These agreements are for a two-year term of employment, except that the term of Dr. Gapontsev’s agreement is three years. All of these agreements will be automatically renewed upon the completion of their initial terms for successive one-year periods unless either we or the executive officer gives 180 days’ prior written notice of intent not to extend the agreement. The agreements entitle these executive officers to participate in any bonus plans, standard insurance plans, such as life, accidental death and dismemberment, short-term disability and long-term disability insurance, and retirement benefits, such as the 401(k) plan and stock option plans described above, on similar terms and on a


19


 

similar basis as such benefits are available to executives at similar levels within the organization. The agreements for Drs. Gapontsev, Shcherbakov and Ovtchinnikov require each of them to refrain from competing with us for a period of one year following the termination of their employment with us for any reason and from hiring our employees or soliciting our customers for a period ending on the later of March 1, 2008 or 18 months following the termination of their employment with us for any reason. These employment agreements also provide for payment of any unpaid bonus award to the respective executive officer in the event his employment with us is terminated as a result of his disability or to his estate if his employment is terminated as a result of his death.
 
We have also entered into indemnification agreements with all of our named executive officers, and we have purchased directors’ and officers’ liability insurance. Our Certificate of Incorporation limits the personal liability of our officers for breaches by them of their fiduciary duties. Our Certificate of Incorporation requires us to indemnify our officers to the fullest extent permitted by the Delaware General Corporation Law.
 
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki